LRP-1 Pathway Targeted Inhibition of Vascular Abnormalities in the Retina of Diabetic Mice

References

• Wong TY, Klein R, Islam FM, Cotch MF, Folsom AR, Klein BE et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006;141:446–455.
   PubMed Web of Science ®Google Scholar
• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376:124–36.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee PS, Huq TS, Potter V, Young A, Davenport IR, Graves R et al. High-glucose-induced endothelial cell injury is inhibited by a Peptide derived from human apolipoprotein E. PLoS One 2012;7:e52152.
   PubMed Web of Science ®Google Scholar
• Shteingauz A, Boyango I, Naroditsky I, Hammond E, Gruber M, Doweck I et al. Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy. Cancer Res 2015;75:3946–3957.
   PubMed Web of Science ®Google Scholar
• Das A, McGuire PG, Rangasamy S. Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology 2015;122:1375–1394.
   PubMed Web of Science ®Google Scholar
• Navaratna D, Menicucci G, Maestas J, Srinivasan R, McGuire P, Das A. A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes. FASEB J 2008;22:3310–3317.
   PubMed Web of Science ®Google Scholar
• Palenski TL, Sorenson CM, Sheibani N. Inflammatory cytokine-specific alterations in retinal endothelial cell function. Microvasc Res 2013;89:57–69.
   PubMed Web of Science ®Google Scholar
• Mohammad G, Kowluru RA. Novel role of mitochondrial matrix metalloproteinase-2 in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011;52:3832–3841.
   PubMed Web of Science ®Google Scholar
• Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res 2006;66:1455–1463.
   PubMed Web of Science ®Google Scholar
• Montel V, Gaultier A, Lester RD, Campana WM, Gonias SL. The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development. Cancer Res 2007;67:9817–9824.
   PubMed Web of Science ®Google Scholar
• Zilberberg A, Yaniv A, Gazit A. The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway. J Biol Chem 2004;279:17535–17542.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Hui DY. Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. J Biol Chem 2003;278:36257–36263.
   PubMed Web of Science ®Google Scholar
• Hui DY, Basford JE. Distinct signaling mechanisms for apoE inhibition of cell migration and proliferation. Neurobiol Aging 2005;26:317–323.
   PubMed Web of Science ®Google Scholar
• Anderson DH, Ozaki S, Nealon M, Neitz J, Mullins RF, Hageman GS et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol 2001;131:767–781.
   PubMed Web of Science ®Google Scholar
• Mulder M, Blokland A, van den Berg DJ, Schulten H, Bakker AH, Terwel D et al. Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging. Lab Invest 2001;81:953–960.
   PubMed Web of Science ®Google Scholar
• Weisgraber KH. Apolipoprotein E: structure-function relationships. Adv Protein Chem 1994;45:249–302.
   PubMedGoogle Scholar
• Dobson CB, Sales SD, Hoggard P, Wozniak MA, Crutcher KA. The receptor-binding region of human apolipoprotein E has direct anti-infective activity. J Infect Dis 2006;193:442–450.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee PS, Huq TS, Mandal TK, Graves RA, Muniruzzaman S, Clement C, et al. A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis. PLoS One 2011;6:e15905.
   PubMed Web of Science ®Google Scholar
• Xu X, Weng Y, Xu L, Chen H. Sustained release of Avastin® from polysaccharides cross-linked hydrogels for ocular drug delivery. Int J Biol Macromol 2013;60:272–276.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu J, Zhang X, Zhang R, Huang Y, Wu C. In Situ Gelling Gelrite/Alginate Formulations as Vehicles for Ophthalmic Drug Delivery. AAPS PharmSciTech 2010;11(2):610–620.
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention. J Pharmacy Bioallied Sci 2015;7:9–14.
   PubMed Web of Science ®Google Scholar
• Hu C, Feng H, Zhu C. Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system. Colloids Surf B Biointerfaces 2012;95:162–169.
   PubMed Web of Science ®Google Scholar
• Mandal S, Thimmasetty MK, Prabhushankar G, Geetha M. Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride. Int J Pharm Investig 2012;2:78–82.
   PubMedGoogle Scholar
• Mao H, Lockyer P, Townley-Tilson WH, Xie L, Pi X. LRP1 regulates retinal angiogenesis by inhibiting PARP-1 activity and endothelial cell proliferation. Arterioscler Thromb Vasc Biol 2016;36:350–360.
   PubMed Web of Science ®Google Scholar
• Foca C, Moses EK, Quinn MA, Rice GE. Differential expression of the alpha(2)-macroglobulin receptor and the receptor associated protein in normal human endometrium and endometrial carcinoma. Mol Hum Reprod 2000;6:921–927.
   PubMed Web of Science ®Google Scholar
• Kancha RK, Stearns ME, Hussain MM. Decreased expression of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells. Oncol Res 1994;6:365–372.
   PubMed Web of Science ®Google Scholar
• Meng H, Chen G, Zhang X, Wang Z, Thomas DG, Giordano TJ, et al. Stro- mal LRP1 in lung adenocarcinoma predicts clinical outcome. Clin Cancer Res 2011;17:2426–2433.
   PubMed Web of Science ®Google Scholar
• Desrosiers RR, Rivard ME, Grundy PE, Annabi B. Decrease in LDL receptor- related protein expression and function correlates with advanced stages of Wilms tumors. Pediatr Blood Cancer 2006;46:40–49.
   PubMed Web of Science ®Google Scholar
• Huang XY, Shi GM, Devbhandari RP, Ke AW, Wang Y, Wang XY, et al. Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection. PLoS One 2012;7:32775.
   Web of Science ®Google Scholar
• Song H, Li Y, Lee J, Schwartz AL, Bu G. Low-density lipoprotein receptor- related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9. Cancer Res 2009;69:879–886.
   PubMed Web of Science ®Google Scholar
• Zhao L, Patel SH, Pei J, Zhang K. Antagonizing Wnt pathway in diabetic retinopathy. Diabetes 2013;62:3993–3995.
   PubMed Web of Science ®Google Scholar
• Jingsheng Tuo, Yujuan Wang, Rui Cheng, Yichao Li, Mei Chen, Fangfang Qiu et al. Wnt signaling in age-related macular degeneration: human macular tissue and mouse model. J Transl Med 2015;13:330.
   PubMed Web of Science ®Google Scholar